Comment
. 2006 Sep;130(3):930-1; author reply 931.
doi: 10.1378/chest.130.3.930.
Comments on the Salmeterol Multicenter Asthma Research Trial
- PMID: 16963702
- DOI: 10.1378/chest.130.3.930
Item in Clipboard
Comment
Comments on the Salmeterol Multicenter Asthma Research Trial
Chest.
2006 Sep.
No abstract available
Comment on
-
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.Chest. 2006 Jan;129(1):15-26. doi: 10.1378/chest.129.1.15. Chest. 2006. PMID: 16424409 Clinical Trial.
Similar articles
-
Why SMART about second-line treatment when first-line treatment is being ignored?Chest. 2006 Sep;130(3):929; author reply 929. doi: 10.1378/chest.130.3.929. Chest. 2006. PMID: 16963701 No abstract available.
-
Cause of death in the SMART Trial.Chest. 2006 Sep;130(3):929-30; author reply 930. doi: 10.1378/chest.130.3.929-a. Chest. 2006. PMID: 16963700 No abstract available.
-
Safety of long-acting beta-agonists--an urgent need to clear the air.N Engl J Med. 2005 Dec 22;353(25):2637-9. doi: 10.1056/NEJMp058299. N Engl J Med. 2005. PMID: 16371628 No abstract available.
-
Salmeterol (Serevent) asthma trial halted early.CMAJ. 2003 Mar 18;168(6):738. CMAJ. 2003. PMID: 12642431 Free PMC article. Review. No abstract available.
-
Safety of long-acting beta-agonists: are new data really required?Chest. 2009 Aug;136(2):604-607. doi: 10.1378/chest.09-1214. Epub 2009 Jun 8. Chest. 2009. PMID: 19505986 Review.
Cited by
-
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD.Chest. 2014 Dec;146(6):1531-1542. doi: 10.1378/chest.14-0117. Chest. 2014. PMID: 25451347 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
